Acurx Pharmaceuticals LLC (ACXP NASDAQ) stock market data APIs
$0.7269
-0.07(-9.6%)
as of June 18, 2025
Try our APIs with
free plan!
Acurx Pharmaceuticals LLC Financial Data Overview
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumonia; and CCP, multiple product candidates for gram-positive infections. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.
Prev. Close
0.7269
Open
0.6557
High
0.7486
Low
0.6517
52 wk Range
0.3-3.325
Market Cap
16 907 K
Shares Outstanding
23 482 K
EPS
-0.11
Beta
-1.372
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Acurx Pharmaceuticals LLC data using free add-ons & libraries
Get Acurx Pharmaceuticals LLC Fundamental Data
Acurx Pharmaceuticals LLC Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-13
- EPS/Forecast: -0.14
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Acurx Pharmaceuticals LLC News
New
Are Medical Stocks Lagging Acurx Pharmaceuticals (ACXP) This Year?
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Acurx Pharmaceuticals, Inc. (ACXP) been one of those stocks this year? Let's tak...
Acurx Pharmaceuticals, Inc. Announces Exercise of Warrants for $2.67 Million Gross Proceeds
STATEN ISLAND, N.Y., June 17, 2025 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics f...
Acurx Pharmaceuticals, Inc. (ACXP): Insider Were Buying In Q1 2025
We recently published a list of 10 Micro-Cap Stocks Insiders Were Buying In Q1 2025. In this article, we are going to take a look at where Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) stands against othe...
DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025
ATLANTIC CITY, NJ / ACCESSWIRE / November 27, 2024 / DealFlow Events is pleased to announce the initial lineup of companies participating in The Microcap Conference, set for January 28-30 in Atlantic ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
